Zhongyang Lu

Dr. Lu has a broad background in clinical and basic sciences, with specific training and expertise in cell culture, ophthalmology, neuroscience and diabetes. His long-term goal is to facilitate the development of a therapeutic for intraocular inflammatory diseases, starting with dry agerelated macular degeneration by shining light on the pathological mechanisms involved and the effects of Oculogenex’ therapy in the retina. Dr, Lu graduated with an MD from Shenyang Medical College and a PhD from Nagasaki University.